BioCentury
ARTICLE | Top Story

Synageva raises $100 million

July 10, 2012 11:50 PM UTC

Synageva BioPharma Corp. (NASDAQ:GEVA) raised $100 million through the sale of 2.4 million shares at $41.20 in a bumped-up follow-on underwritten by Morgan Stanley; JPMorgan; Cowen; Leerink; Canaccord...